Jean M Bidlack

Title: Innovations and Contributions of Jean M Bidlack

Introduction

Jean M Bidlack is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of treatments for diseases associated with G protein signaling and cocaine abuse. With a total of 4 patents, his work has had a profound impact on medical research and therapeutic applications.

Latest Patents

Bidlack's latest patents include innovative compositions and methods for inhibiting G protein signaling. These inventions focus on treating diseases linked to G protein βγ subunit activity. Another significant patent addresses the treatment of cocaine abuse using N-substituted derivatives of morphinan. This invention is based on the discovery that nonselective κ agonists, which also possess μ receptor-mediated effects, can effectively reduce cocaine self-administration with fewer side effects compared to highly selective κ agonists. The compounds developed in this patent are not only useful for treating cocaine abuse but can also be radiolabeled for imaging purposes, such as positron emission tomography (PET) and single photon computed tomography (SPECT) brain imaging.

Career Highlights

Throughout his career, Bidlack has worked with esteemed institutions, including the University of Rochester and the McLean Hospital Corporation. His research has been pivotal in advancing our understanding of opioid receptors and their role in addiction and disease treatment.

Collaborations

Bidlack has collaborated with notable colleagues, including Xiao-Hui Gu and John L Neumeyer. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Jean M Bidlack's innovative work and patents have significantly advanced the field of pharmacology. His contributions continue to influence research and treatment strategies for various medical conditions.